Form D · Other Health Care
Infinity Bio, Inc.
Baltimore, MD · CIK 0001982572
Offering snapshot reported Aug 20, 2025 · SEC filing
- Reported sold
- $5M Offering amount: $7M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Jun 13, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 20, 2025 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Mar 11, 2025 | Initial | $2,000,000 | No comparison | 2 | SEC filing |
| Jun 3, 2024 | Amendment | $4,516,093 | $2,016,093vs Jun 26, 2023 | 1 | SEC filing |
| Jun 26, 2023 | Initial | $2,500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-555297
Source: Form D, filed Aug 20, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bill Campbell | Director |
| Malek Fahem | Director |
| Matthew Hellauer | Director |
| Benjamin Larman | Director, Executive |
| H. Benjamin Larman | Director, Executive |
| Joy Nassif | Director, Executive |
| Caroline Popper | Director |
| Herman Scholtz | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
6200 Seaforth St.
Baltimore, MD, 21224
Baltimore, MD, 21224